Zai Lab (ZLAB) “announced that China’s National Medical Products Administration has accepted the Biologics License Application for TIVDAK, tisotumab vedotin-tftv, for the treatment of patients ...

Leerink Partners analyst Jonathan Chang maintained a Buy rating on Zai Lab (NASDAQ:ZLAB) Ltd on Thursday, setting a price target ...

Lu Jianjun is a Chinese artist born in 1960. He is known for his contributions to contemporary art and has gained recognition in various exhibitions. Lu Jianjun studied at the Central Academy of Fine ...

After hours: March 14 at 7:39:12 PM EDT Loading Chart for ZLAB ...